WIPO logo
Mobile | Deutsch | Español | Français | 日本語 | 한국어 | Português | Русский | 中文 | العربية |
PATENTSCOPE

Search International and National Patent Collections
World Intellectual Property Organization
Search
 
Browse
 
Translate
 
Options
 
News
 
Login
 
Help
 
Machine translation
1. (WO2011140125) METHODS OF CHARACTERIZING HOST RESPONSIVENESS TO INTERFERON BY EX VIVO INDUCTION OF INTERFERON-RESPONSIVE MARKERS
Latest bibliographic data on file with the International Bureau   

Pub. No.:    WO/2011/140125    International Application No.:    PCT/US2011/035045
Publication Date: 10.11.2011 International Filing Date: 03.05.2011
IPC:
C12Q 1/00 (2006.01), G01N 33/48 (2006.01)
Applicants: HITACHI CHEMICAL CO., LTD. [JP/JP]; 1-1 Nishi-shinjuku 2-chome, Shinjuku-ku Tokyo, 163-0449 (JP) (For All Designated States Except US).
HITACHI CHEMICAL RESEARCH CENTER, INC. [US/US]; 1003 Health Sciences Road Irvine, CA 92617 (US) (For All Designated States Except US).
MITSUHASHI, Masato [US/US]; (US) (For US Only).
BORDEN, Ernest, C. [US/US]; (US) (For US Only)
Inventors: MITSUHASHI, Masato; (US).
BORDEN, Ernest, C.; (US)
Agent: ALTMAN, Daniel, E.; Knobbe, Martens, Olson & Bear, LLP 2040 Main Street, 14th Floor Irvine, CA 92614 (US)
Priority Data:
61/332,677 07.05.2010 US
61/387,668 29.09.2010 US
Title (EN) METHODS OF CHARACTERIZING HOST RESPONSIVENESS TO INTERFERON BY EX VIVO INDUCTION OF INTERFERON-RESPONSIVE MARKERS
(FR) PROCÉDÉS DE CARACTÉRISATION DE LA SENSIBILITÉ D'UN HÔTE À L'INTERFÉRON PAR INDUCTION EX VIVO DE MARQUEURS DE RÉPONSE À L'INTERFÉRON
Abstract: front page image
(EN)Embodiments of the invention relate generally to ex vivo methods of quantifying expression of interferon responsive genes and characterizing an individual's potential responsiveness to interferon administration. Certain embodiments relate to methods to monitor the efficacy of ongoing interferon therapy by evaluating expression of interferon responsive genes before and after interferon administration.
(FR)Des modes de réalisation de l'invention concernent de manière générale des procédés ex vivo de quantification de l'expression de gènes de réponse à l'interféron et de caractérisation de la sensibilité potentielle d'un individu à l'administration d'interféron. Certains modes de réalisation concernent des procédés pour contrôler l'efficacité d'une thérapie par interféron en cours en évaluant l'expression de gènes de réponse à l'interféron avant et après d'administration d'interféron.
Designated States: AE, AG, AL, AM, AO, AT, AU, AZ, BA, BB, BG, BH, BR, BW, BY, BZ, CA, CH, CL, CN, CO, CR, CU, CZ, DE, DK, DM, DO, DZ, EC, EE, EG, ES, FI, GB, GD, GE, GH, GM, GT, HN, HR, HU, ID, IL, IN, IS, JP, KE, KG, KM, KN, KP, KR, KZ, LA, LC, LK, LR, LS, LT, LU, LY, MA, MD, ME, MG, MK, MN, MW, MX, MY, MZ, NA, NG, NI, NO, NZ, OM, PE, PG, PH, PL, PT, RO, RS, RU, SC, SD, SE, SG, SK, SL, SM, ST, SV, SY, TH, TJ, TM, TN, TR, TT, TZ, UA, UG, US, UZ, VC, VN, ZA, ZM, ZW.
African Regional Intellectual Property Organization (BW, GH, GM, KE, LR, LS, MW, MZ, NA, SD, SL, SZ, TZ, UG, ZM, ZW)
Eurasian Patent Organization (AM, AZ, BY, KG, KZ, MD, RU, TJ, TM)
European Patent Office (AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR)
African Intellectual Property Organization (BF, BJ, CF, CG, CI, CM, GA, GN, GQ, GW, ML, MR, NE, SN, TD, TG).
Publication Language: English (EN)
Filing Language: English (EN)